Guiding Regulatory Frameworks
I provide specialized support for the design, commissioning, and qualification of isolator-based filling systems in full compliance with:
EU GMP Annex 1 – Emphasizing Contamination Control Strategies (CCS) around interventions, air handling, transfer processes, and decontamination cycles.
FDA’s Guidance for Sterile Drug Products Produced by Aseptic Processing – Emphasizing an equipment design and qualification approach to yield reliable, repeatable media fill performance.
Services Offered
1. Design Qualification (DQ) & Project Initiation
Conceptual & Mock-up Design Verification for:
Operator ergonomics in equipment set-up and production phase operations
Compatibility of critical work surface design with first-air principles
Isolator chamber zoning and pressure cascade
Material transfer feasibility (e.g., via RTPs, MTCs, or tunnel-fed isolators)
Mapping of viable and non-viable particle monitoring across isolator and support zones
EM location mapping in compliance with Annex 1 EM expectations
Alignment with CCS and trend-based monitoring strategies
Alignment with Annex 1 expectations for isolator justification and design.
2. FAT/SAT & Commissioning
FAT/SAT verification of:
I/O loops, alarming, HMI functions, interlocks, and container handling.
Glove integrity recipes, VHP cycles, leak testing, and fixture design.
Traceable commissioning documentation to support smooth transition into IQ/OQ.
3. Qualification Execution – IQ/OQ
Generation and execution of IQ/OQ protocols covering:
HEPA airflow and filter leak integrity
Glove leak tests (pressure decay)
Air classification per ISO 14644
User Access & Permissions, Audit Trail, Backup & Restore, Reporting, Facility Integration
In-process controls (IPC) for fill weight and reject logic
4. Performance Qualification (PQ) & Media Fills
Development & Execution of Performance Qualifications (PQ):
VHP decontamination coverage & efficacy
Static & Dynamic EMPQ
Container closure integrity (CCI)Â testing
Process holding and changeover scenarios
Development & Execution of Aseptic Process Simulations (APS):
Simulation of worst-case interventions and batch conditions
Execution across multiple shifts and configurations
Bracket establishment to challenge representative container/closure systems and fill volumes
Documentation per FDA and Annex 1 expectations
5. Ancillary Program/Parameter Development:
Isolator environmental monitoring
Isolator glove testing
Isolator product-contact component autoclaving and hold
Isolator VHP sterility hold
Routine & non-routine intervention Definition & risk assessment
Aseptic process simulation (APS) program development
APS bracket matrix development
System Expertise
Optima MultiUse (Filling & Closing Systems)
SKAN VarioSys (Modular Isolator Platforms)
Bausch & Stroebel KSF (Modular Filling Machines)
IMA Xtrema (High-Speed Vial/Bottle Fillers)
Bosch (Syntegon) Filling and Barrier Technology